TY  - JOUR
AU  - Pérez Diego, Mario
AU  - Angelina Querencias, Alba
AU  - Pat, Yağız
AU  - Maldonado, Angel
AU  - Sevilla Ortega, Carmen
AU  - Martín De La Cruz, Leticia
AU  - Yazici, Duygu
AU  - Rückert,  Beate
AU  - Sokolowska, Milena
AU  - Martín-Fontecha Corrales, María Del Mar
AU  - Akdis , Mübeccel
AU  - Akdis, Cezmi A
AU  - Palomares Gracia, Óscar
PY  - 2025
DO  - 10.1016/j.jaci.2025.05.002
UR  - https://hdl.handle.net/20.500.14352/122508
T2  - Journal of Allergy and Clinical Immunology
AB  - Background: Viral infections and type 2 immune responses perpetuate airway epithelial barrier dysfunction and inflammation, leading to the development and progression of asthma. The synthetic cannabinoid WIN55,212-2 displays anti-inflammatory...
LA  - eng
PB  - PubMed
KW  - Cannabinoids
KW  - WIN55,212-2
KW  - Airway epithelial cells
KW  - Asthma
KW  - Metabolic reprogramming
KW  - Oxidative stress
KW  - Type 2 cytokine signaling
KW  - Type 2 inflammation
KW  - Viral infections
TI  - Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation
TY  - journal article
ER  -